BI 3812465 / Boehringer Ingelheim - LARVOL DELTA

A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated (clinicaltrials.gov) - P1/2 | N=49 | Not yet recruiting | Sponsor: Boehringer Ingelheim

First-in-human • New P1/2 trial • Diabetic Macular Edema • Ophthalmology

A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated (clinicaltrials.gov) - P1/2 | N=49 | Recruiting | Sponsor: Boehringer Ingelheim | Not yet recruiting ➔ Recruiting

Enrollment open • First-in-human • Diabetic Macular Edema • Ophthalmology